ST Pharm
ST Pharm
01
Who we are
02
Our record
03
Newsroom
04
Contact
En
Ko
ST Pharm
Science & Technology
Business Overview
CDMO
Small Molecule
Oligonucleotide
mRNA
CRO
AnaPath Research & Service
R&D
Virtual R&D
Global R&D
About
ST PHARM
Key Members
History
Global Approval
ST Pharm Family
CI
Public
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
Careers
ESG
Overview
Environmental
Social
Governance
Sitemap
Contact
Linkedin
Public
ST PHARM News
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
ST PHARM's Public Release
All
Media Focus
ST PHARM News
ST PHARM News
[ST Pharm Leaflet] Generic API
Oct 31, 2023
ST PHARM News
[ST Pharm Leaflet] Monomer
Oct 31, 2023
ST PHARM News
[ST Pharm Leaflet] Oligonucleotide CDMO
Oct 31, 2023
ST PHARM News
[ST Pharm Leaflet] mRNA CDMO (SmartCap® STLNP®)
Oct 31, 2023
ST PHARM News
ST Pharm Upcoming Events
Oct 15, 2023
ST PHARM News
ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility
Sep 19, 2023
ST PHARM News
[Inovation Center Time lapse Movie]
Mar 6, 2023
ST PHARM News
ST PHARM participated in 2023 JP Morgan healthcare conference
Jan 4, 2023
ST PHARM News
ST PHARM, 2022 KCGS ESG rating 'B+'
Dec 5, 2022
ST PHARM News
ST PHARM, 2022 Sustinvest ESG Rating 'AA'
Nov 18, 2022
ST PHARM News
ST PHARM Participated in 10th International mRNA Health Conference
Oct 31, 2022
ST PHARM News
ST PHARM, Participated in CPHI 2022 Frankfrut
Oct 17, 2022
ST PHARM News
ST PHARM, Frost & Sullivan Best Practices Virtual Awards Ceremony
Aug 17, 2022
2
of
3